Walgreens to acquire Express Scripts

DEERFIELD, Ill. Walgreens announced that through its subsidiary OptionCare Enterprises it will acquire Express Scripts, a Louisville, Ky.-based home infusion pharmacy division. Terms of the agreement were not disclosed. The parties expect the transaction to close within 30 days.

“This acquisition further expands our national coverage in home infusion services,” said Paul Mastrapa, president of Walgreens-OptionCare. “CuraScript IP is highly regarded in the industry for its clinical expertise and commitment to exceptional patient care. We welcome this addition to our infusion pharmacy network and look forward to reaching even more patients with this combined high level of personalized therapy and support.”